We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
Cap. Flow
+$4.06B
Cap. Flow %
5.93%
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$124M
2
AAPL icon
Apple
AAPL
+$110M
3
MSFT icon
Microsoft
MSFT
+$104M
4
AMZN icon
Amazon
AMZN
+$71.3M
5
WBD icon
Warner Bros
WBD
+$69.6M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$61.6M
2
CERN
Cerner Corp
CERN
+$50.9M
3
NXPI icon
NXP Semiconductors
NXPI
+$31.4M
4
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$30.4M
5
YUMC icon
Yum China
YUMC
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Healthcare 14.42%
3 Financials 13.45%
4 Consumer Discretionary 10.49%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOFT icon
3151
Hooker Furnishings Corp
HOFT
$163M
-15,825
Closed -$300K
HOFV
3152
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
-2,617
Closed -$64K
HOOK
3153
DELISTED
HOOKIPA Pharma
HOOK
-1,412
Closed -$32K
HOWL icon
3154
Werewolf Therapeutics
HOWL
$19.6M
-22,550
Closed -$99K
HPK icon
3155
HighPeak Energy
HPK
$867M
-9,354
Closed -$208K
HRTG icon
3156
Heritage Insurance Holdings
HRTG
$1.07B
-31,540
Closed -$225K
IBIO icon
3157
iBio
IBIO
$69.1M
-455
Closed -$97K
ICAD
3158
DELISTED
iCAD Inc
ICAD
-19,635
Closed -$88K
IJJ icon
3159
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.9B
-3,900
Closed -$428K
IJK icon
3160
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11B
-2,800
Closed -$216K
IJS icon
3161
iShares S&P Small-Cap 600 Value ETF
IJS
$8.26B
-2,300
Closed -$235K
IMA
3162
ImageneBio Inc
IMA
$63.9M
-2,397
Closed -$175K
IMRX icon
3163
Immuneering
IMRX
$289M
-13,819
Closed -$89K
IMUX icon
3164
Immunic
IMUX
$198M
-2,212
Closed -$250K
INFU icon
3165
InfuSystem Holdings
INFU
$236M
-16,232
Closed -$159K
INZY
3166
DELISTED
Inozyme Pharma
INZY
-12,890
Closed -$53K
IRON icon
3167
Disc Medicine
IRON
$2.97B
-577
Closed -$24K
KALA icon
3168
KALA BIO
KALA
$14.2M
-27
Closed -$94K
TBHC
3169
DELISTED
The Brand House Collective
TBHC
-12,205
Closed -$113K
KLTR icon
3170
Kaltura
KLTR
$262M
-33,485
Closed -$60K
KOPN icon
3171
Kopin
KOPN
$756M
-75,354
Closed -$191K
KRRO icon
3172
Korro Bio
KRRO
$178M
-815
Closed -$86K
KVHI icon
3173
KVH Industries
KVHI
$162M
-20,532
Closed -$187K
LAB icon
3174
Standard BioTools
LAB
$314M
-96,009
Closed -$345K
LCTX icon
3175
Lineage Cell Therapeutics
LCTX
$282M
-101,742
Closed -$157K

Similar funds

RhumbLine Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.

  • RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
  • RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
  • RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
  • RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
  • RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
  • RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.